Epiomic Epidemiology Series Reports

In an effort to provide a more condensed version of our Epiomic Patient segmentation database for our clients, we have developed a new range of reports called the Epiomic Epidemiology Series. Each of these publications will be disease specific and will typically cover between 8-10 Major Global Markets with a forecasted horizon of 10 years. Each report will begin with some analyst insights about the disease or disorder which will look specifically at the patient population and provide some insight related to:
  • the cause of the disease
  • risk factors and prevention
  • the diagnosis
  • variations by geography or ethnicity,
  • key co morbid conditions associated with the disease
  • disease prognosis and clinical course
The majority of the report will be presented in easy to understand data tables showing the patients prevalence by the specific country across a 10 year horizon period. Each report will have the overall top-line prevalence for the disease in each country along with a split by gender. To add a further level of detail, we have provided a breakdown of the prevalence or incidence population by gender in 5 year cohorts for each country in the report.   A real benefit of using the Epiomic patient segmentation database as a source is its ability to look beyond just the prevalence and incidence rate of a disease, and show relevant sub-populations. These sub-populations could be either a key co-morbid condition or some other attributes that are important to understand when considering the current and future treatment or diagnostic pathway for a specific disease. All of these sub-populations have been displayed in a table format with each population segmented even further by country or other parameters related to the sub-population.   These reports are built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Haemophilia Forecast in 17 Major Markets 2017-2027

September 2017 | Heart & Cardiovascular, Men's Health |

Haemophilia is a collective term describing rare, usually inherited genetic blood coagulation disorders that lead to abnormally long bleeding at the site of wound or injury and, in severe cases, spontaneous bleeding episodes without any apparent injury. The disorders are caused by absent or insufficient activity of blood coagulation factors….

  • AU, BR, CA, CN, FR, DE, GR, IN, IT, JP, MX, PL, RU, ES, TR, UK, US

Graves’ Disease Forecast in 23 Major Markets 2017-2027

Graves’ disease is an autoimmune disease of the thyroid gland, in which the thyroid attacked by the body’s own defence mechanisms becomes enlarged and produces increased amount of hormones, causing hyperthyroidism. The condition induces signs and symptoms that seriously affect the patient’s quality of life, everyday activities and ability to…

  • AT, BR, CA, CN, DK, FR, DE, IS, IN, IT, JP, MX, NL, NO, PL, KR, ES, SE, CH, TR, UK, US

Gastro-Oesophageal Reflux Disease Forecast in 19 Major Markets 2017-2027

September 2017 | GI Disorders |

Gastro-oesophageal reflux disease (GORD) is a common disorder of the upper gastrointestinal tract. According to the most recent definition, it is a condition occurring when reflux of gastric contents causes troublesome symptoms and/or complications. Based on endoscopy findings, the disease is broadly classified into two subtypes: demonstrating oesophageal mucosal damage…

  • AR, AU, BR, CA, CN, FR, DE, IN, IT, JP, MX, NO, RU, KR, ES, SE, TR, UK, US

Cystinosis Forecast in 19 Major Markets 2017-2027

Cystinosis is a rare inherited lysosomal storage disorder caused by mutations in the CTNS gene that encodes cystinosin, a lysosomal cystine–proton co-transporter. This results in an abnormal accumulation of the amino acid cystine within the lysosomes of all body cells and tissues. Although it is a monogenic, autosomal recessive disease,…

  • AR, AU, AT, BR, CA, FR, DE, IN, IE, IT, JP, MX, NL, PL, KR, ES, TR, UK, US

Cerebrotendinous Xanthomatosis Forecast in 18 Major Markets 2017-2027

Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive lipid storage disease caused by mutations in the CYP27A1 gene encoding a cytochrome P450 oxidase, also known as sterol 27-hydroxylase. The lack of the functional enzyme results in a reduced production of chenodeoxycholic acid (CDCA) and cholic acid (CA), components of bile,…

  • AR, AT, BR, CA, CN, FR, DE, IN, IT, JP, MX, NL, PL, RU, ES, TR, UK, US

Acute Decompensated Heart Failure Forecast in 12 Major Markets 2017-2027

September 2017 | Heart & Cardiovascular |

Acute decompensated heart failure (ADHF), a sub-set of chronic heart failure (CHF), is a life-threatening episode during which the heart is not able to supply sufficient blood flow to the body. This requires urgent medical attention. The condition is divided into two subtypes: ADHF with reduced (ADHF-REF) and preserved (ADHF-PEF)…

  • BR, CA, CN, FR, DE, IN, IT, JP, RU, ES, UK, US